A plan has been announced to lower the cost of certain obesity drugs, including GLP-1 medications like Ozempic, with prices potentially as low as $150 per month. The details of the plan and its implementation are not yet certain, with some cautioning that it is not a done deal. If realized, the price reduction could make these medications more accessible to people without insurance, with some retailers like Costco reportedly planning to offer them at a discount.